- Ansys’ adjusted Earnings Per Share (EPS) for the second quarter is $2.50, surpassing last year’s $1.60 and beating the estimated $1.91.
- The annual contract value (ACV) is $520.5 million, a 6.6% increase year-over-year, but below the estimated $539.4 million.
- Company comments indicate expectations of double-digit ACV and revenue growth in the second half of 2024.
- Ansys forecasts that the full-year (FY) 2024 ACV will grow by double digits.
- Analyst recommendations include 2 buys, 11 holds, and 1 sell.
A look at Ansys Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
ANALYSIS: Ansys Inc, a company that specializes in software solutions for design analysis and optimization, has received varying Smart Scores across different factors. While scoring moderately in terms of value and momentum, Ansys Inc excels in resilience and growth, showcasing a strong ability to weather market fluctuations and maintain consistent growth potential. Despite a lower dividend score, the company’s focus on innovation and product development has driven its position in the market.
OUTLOOK: With a solid foundation in resilience and growth, Ansys Inc appears well-positioned for long-term success. The company’s robust software offerings that enhance product development processes and improve efficiency are likely to continue driving its performance. As Ansys Inc further capitalizes on its strengths in resilience and growth, it has the potential to solidify its position as a leading provider of design analysis solutions, catering to a wide range of manufactured products.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
